Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > Price / Sales (ntm)

Aerie Pharmaceuticals Price / Sales (ntm) Chart (AERI)

Aerie Pharmaceuticals annual/quarterly Price / Sales (ntm) from 2017 to 2020.
  • Aerie Pharmaceuticals Price / Sales (ntm) for the quarter ending September 09, 2020 was 5.80 a 5.68% increase of 0.33 year over year
  • Aerie Pharmaceuticals Price / Sales (ntm) for the last 12 months ending September 09, 2020 was 5.80 a 5.68% increase of 0.33 year over year
  • Aerie Pharmaceuticals Annual Price / Sales (ntm) for 2020 was 5.80 a 0.85% increase of 0.05 from 2019
  • Aerie Pharmaceuticals Annual Price / Sales (ntm) for 2020 was 5.75 a 1.20% increase of 0.07 from 2019
  • Aerie Pharmaceuticals Annual Price / Sales (ntm) for 2020 was 5.68 a 3.72% increase of 0.21 from 2019
Other Valuation Metrics:
  • Aerie Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $2,142m a 11.86% increase of 254m year over year
  • Aerie Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 14.78 a -42.15% decrease of -6.23 year over year
  • Aerie Pharmaceuticals Enterprise Value for the quarter ending March 03, 2018 was $2,017m a 10.53% increase of 212m year over year
View Chart On Koyfin

Quarterly AERI Price / Sales (ntm) Data

09/20205.80
09/20205.75
09/20205.68
09/20205.47
09/20205.14
09/20205.33
09/20205.71
09/20205.88
09/20205.73
09/20205.58

Annual AERI Price / Sales (ntm) Data

20205.80
20205.75
20205.68
20205.47
20205.14
20205.33
20205.71
20205.88
20205.73
20205.58